COMPLICATED URINARY TRACT INFECTION
Clinical trials for COMPLICATED URINARY TRACT INFECTION explained in plain language.
Never miss a new study
Get alerted when new COMPLICATED URINARY TRACT INFECTION trials appear
Sign up with your email to follow new studies for COMPLICATED URINARY TRACT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibiotic vabomere tested in kids with tough UTIs
Disease control Recruiting nowThis study is testing an antibiotic called Vabomere in children aged 3 months to 12 years who have complicated urinary tract infections, including kidney infections. The goal is to see if the drug is safe and how the body processes it. About 66 children will receive the medicine …
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE2 • Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC) • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
One shot wonder? new study tests shorter IV treatment for kids with tough UTIs
Symptom relief Recruiting nowThis study compares two treatment plans for children with complicated urinary tract infections (UTIs): one group gets a single IV antibiotic dose followed by two days of oral antibiotics, while the other gets three daily IV doses. Both groups finish with a total of 7 days of anti…
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated May 26, 2026 06:57 UTC
-
New antibiotic zavicefta under Real-World watch in korea
Knowledge-focused Recruiting nowThis study observes how safe and effective Zavicefta is for patients with complicated infections in the abdomen, urinary tract, or lungs (pneumonia) that may be linked to hospital stays. About 600 adults and children aged 3 months and older will be followed after receiving the dr…
Matched conditions: COMPLICATED URINARY TRACT INFECTION
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC